ERG - ETS transcription factor ERG Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102122741
ERG Products (8)
| mRNA | Protein | Name |
|---|---|---|
| XM_005548686.3 | XP_005548743.1 | transcriptional regulator ERG isoform X2 |
| XM_045389305.1 | XP_045245240.1 | transcriptional regulator ERG isoform X2 |
| XM_045389308.1 | XP_045245243.1 | transcriptional regulator ERG isoform X7 |
| XM_005548689.3 | XP_005548746.1 | transcriptional regulator ERG isoform X5 |
| XM_005548687.3 | XP_005548744.1 | transcriptional regulator ERG isoform X4 |
| XM_045389307.1 | XP_045245242.1 | transcriptional regulator ERG isoform X6 |
| XM_045389306.1 | XP_045245241.1 | transcriptional regulator ERG isoform X3 |
| XM_015446856.2 | XP_015302342.1 | transcriptional regulator ERG isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
transcriptional regulator ERG |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-A0148A | Halofantrine hydrochloride | Inhibitor | 99.90% | Yes |
| HY-A0148 | Halofantrine | Inhibitor | / | Unkown |
| HY-A0148AR | Halofantrine hydrochloride (Standard) | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-Y0282 | Sodium bromide | 99.2% | Phase 3 |
Pre-clinical Phase
Bioactive Molecules
(34)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-W193545A | ERG240 | Inhibitor | 98.0% | Unkown |
| HY-162351 | EBP-IN-1 | Inhibitor | 99.77% | Unkown |
| HY-159730 | ERG245 | Inhibitor | 99.49% | Unkown |
| HY-122234 | VPC-18005 | Inhibitor | 99.80% | Unkown |
| HY-N7848 | Linoleamide | Inhibitor | 99.4% | Unkown |
| HY-112158 | NSC139021 | 99.77% | Unkown | |
| HY-16915 | RPR-260243 | Activator | 99.37% | Unkown |
| HY-121964 | cis-Piperidine-2,3-dicarboxylic acid | Agonist | 95.0% | Unkown |
| HY-139893 | ERGi-USU-6 mesylate | Inhibitor | 95.0% | Unkown |
| HY-108592 | UCL 2077 | Inhibitor | 98.91% | Unkown |
| HY-116445 | UNC9975 | Agonist | / | Unkown |
| HY-117744 | NMS-P645 | Inhibitor | / | Unkown |
| HY-124057 | RO5126946 | Activator | / | Unkown |
| HY-144694 | HDAC/HSP90-IN-3 | Inhibitor | / | Unkown |
| HY-145814 | HSP90-IN-9 | Inhibitor | / | Unkown |
| HY-159585 | CYP51-IN-20 | Inhibitor | / | Unkown |
| HY-175663 | EYE-002 | Inhibitor | / | Unkown |
| HY-175664 | EYE-003 | Inhibitor | / | Unkown |
| HY-180918 | ERG-IN-4 | / | Unkown | |
| HY-180919 | ERG-IN-5 | Inhibitor | / | Unkown |
| HY-181103 | ERG-IN-6 | / | Unkown | |
| HY-183202 | NCD38 | / | Unkown | |
| HY-184190 | ERG-IN-7 | Inhibitor | / | Unkown |
| HY-P1426 | AmmTX3 | Inhibitor | / | Unkown |
| HY-P5806 | Ergtoxin-1 | Antagonist | / | Unkown |
| HY-RS04491 | ERG Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04492 | ERG28 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04493 | ERGIC1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04494 | ERGIC3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W749520 | Zymosterone | / | Unkown | |
| HY-117523 | (Z)-RG-13022 | Inhibitor | / | Unkown |
| HY-184314 | Antifungal agent-166 | Inhibitor | / | Unkown |
| HY-RS16711 | Erg Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23146 | Erg Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991886 | ANX-M1 (Human IgG1) | Inhibitor | 99.0% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service